No Upcoming Event

MONITORING AND EVALUATION

The National Cancer Institute-Kenya (NCI-K) was established through the Cancer Prevention and Control Act No.15 of 2012. The institute is mandated to provide good quality health information that is essential for planning and implementation of Cancer policies and strategies. Monitoring, Evaluation and Research and Development directorates is mandated to provide Cancer information in a timely manner to enable the country have information necessary to fight the Cancer threat and plan for the future of its citizens. This is achieved through improved data collection processes, management and reporting of reliable data for fact-based decision-making and policy making and research to reduce the incidence, morbidity and mortality associated with cancer and to improve the lives of all Kenyans.

The DIRECTORATE has three (3) Divisions namely:
• Measurement, Learning and Accountability;
• Research and Development and
• Cancer Registry.

Monitoring and evaluation
Monitoring and Evaluation (M&E) is a critical function in the Prevention and Control of Cancer, tasked with the development of a National Cancer Monitoring and Evaluation (M&E) framework which will guide the harmonization and alignment of data and M&E processes in a collaborative way. The framework will provide standardized and clearly defined measurable indicators and data collection tools to facilitate the assessment the performance of the institute towards achieving its intended targets and goals. The framework will also provide a robust approach to evaluations and surveillance to measure outcomes and impact of the institute’s strategic plan Dissemination mechanisms will be established to promote transparency and enhance accountability at national, county and community levels.

THE NATIONAL CANCER REGISTRY

The Cancer Prevention and Control Act, No. 15 of 2012 spells out 5 specific functions of the National Cancer Institute of Kenya (NCI-K) under Section 5 on cancer data as follows:

  • collect, analyze and disseminate all data useful in the prevention, diagnosis and treatment of cancer;
  • collect, catalogue, store and disseminate the results of cancer research undertaken in any country for the use of any person involved in cancer research;
  • ensure that accurate figures of persons with cancer are obtained in the country for purposes of planning
  • provide access to available information and technical assistance to all institutions, associations and organizations concerned with the welfare and treatment of persons with cancer
  • encourage and participate in the provision of training on cancer prevention and control

In order to deliver on these responsibilities as required by the law, the institute is thus mandated to maintain a Cancer Registry (PART III, Section 20 , 21 and 22 of the Act) containing:

  • Individual level Cancer Patient data - Incidence, Prevalence, Type, Trends, Location e.t.c
  • Institutions, Associations & Organizations providing cancer services
  • Catalogue & Dissemination of cancer research undertaken in any country (Sec 5 - f)
It is a law requirement to notify the institute within 60 days of cancer diagnosis failure to which a fine not exceeding two hundred thousand shillings, imprisonment for a term, not exceeding two years or both may be preferred to any person contravening this law .

The notification format will be as prescribed by the National Cancer Institute of Kenya.

Shaping the Future of Cancer Research in Kenya

The National Cancer Institute of Kenya is charged with the responsibility of coordinating cancer-related research to inform policy and practice. This is in line with the aspirations of the National Cancer Control Strategy for Kenya, 2017-2022 that highlighted research as a central strategy in all cancer control planning in the country. Although there has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace. The Institute is thus keen on cancer disparities and equity research and is therefore prioritizing the following research areas:

  • Basic science of pre-malignancy and prevention
  • Biomarkers, early detection, and screening
  • Cancer in minority populations and cancer health disparities
  • Risk factors: social determinants, environment/physical determinants, biological factors, behavioral factors, protective and/or Resiliency factors and Co-morbidities
  • Cancer interception
  • Clinical epidemiology, lifestyle, and environmental risk factors
  • Molecular epidemiology, cancer genetics, and predisposition genes
  • Precision cancer prevention
  • Precision molecular diagnostics
  • Post-treatment surveillance, survivorship and energetics
  • Financially sustainable models for cancer care
  • Cancer workforce utilization models
  • Best palliation models

As the country’s lead institution for cancer prevention and control, NCI-Kenya advises the Cabinet Secretary for Health, on policy matters relating to the prevention, treatment and control of cancer. This is through a systematic analysis of all cancer prevention and control activities undertaken by various stakeholders to determine the gaps and make recommendations on the investment priorities for the country.

Talk To Us

Our Contacts

6th Floor, Landmark Plaza, Off Argwings Kodhek Road, Upperhill, Nairobi, KE

P.O. Box 30016 - 00100, G.P.O Nairobi

(+254) 0717 389 120

support@ncikenya.or.ke